$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 2 3 4 5 6 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Grant | A | 0.00 | 6,661 | 0 | 158,849 | 152.2 K to 158.8 K (+4.38 %) |
Jul 07 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | A | 106.47 | 2,534 | 269,795 | 2,534 | |
Jul 07 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Payment of Exercise | F | 107.79 | 104 | 11,210 | 24,598 | 24.7 K to 24.6 K (-0.42 %) |
Jul 07 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Payment of Exercise | F | 106.47 | 564 | 60,049 | 24,702 | 25.3 K to 24.7 K (-2.23 %) |
Jul 07 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Grant | A | 0.00 | 3,532 | 0 | 25,266 | 21.7 K to 25.3 K (+16.25 %) |
Jul 07 2020 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Payment of Exercise | F | 107.97 | 273 | 29,476 | 53,407 | 53.7 K to 53.4 K (-0.51 %) |
Jul 07 2020 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Payment of Exercise | F | 106.47 | 1,474 | 156,937 | 53,680 | 55.2 K to 53.7 K (-2.67 %) |
Jul 07 2020 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Grant | A | 0.00 | 6,661 | 0 | 55,154 | 48.5 K to 55.2 K (+13.74 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 68.62 | 10,437 | 716,187 | 12,334 | |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 72.27 | 10,437 | 754,282 | 12,335 | |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 83.83 | 12,132 | 1,017,026 | 1,194 | |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 83.83 | 596 | 49,963 | 0 | |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 107.31 | 10,437 | 1,119,994 | 100,750 | 111.2 K to 100.8 K (-9.39 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 68.62 | 10,437 | 716,187 | 111,187 | 100.8 K to 111.2 K (+10.36 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 107.31 | 10,437 | 1,119,994 | 100,750 | 111.2 K to 100.8 K (-9.39 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 72.27 | 10,437 | 754,282 | 111,187 | 100.8 K to 111.2 K (+10.36 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 107.31 | 12,132 | 1,301,885 | 100,750 | 112.9 K to 100.8 K (-10.75 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 83.83 | 12,132 | 1,017,026 | 112,882 | 100.8 K to 112.9 K (+12.04 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 107.31 | 596 | 63,957 | 100,750 | 101.3 K to 100.8 K (-0.59 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 83.83 | 596 | 49,963 | 101,346 | 100.8 K to 101.3 K (+0.59 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 106.40 | 2,522 | 268,341 | 100,750 | 103.3 K to 100.8 K (-2.44 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Payment of Exercise | F | 107.79 | 269 | 28,996 | 103,272 | 103.5 K to 103.3 K (-0.26 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Payment of Exercise | F | 106.47 | 1,474 | 156,937 | 103,541 | 105 K to 103.5 K (-1.40 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Grant | A | 0.00 | 6,661 | 0 | 105,015 | 98.4 K to 105 K (+6.77 %) |
Jul 07 2020 | INCY | INCYTE CORP | Stamoulis Christiana | EVP & Chief Financi ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Stamoulis Christiana | EVP & Chief Financi ... | Grant | A | 0.00 | 6,661 | 0 | 21,067 | 14.4 K to 21.1 K (+46.24 %) |
Jul 07 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Payment of Exercise | F | 106.47 | 2,373 | 252,653 | 27,949 | 30.3 K to 27.9 K (-7.83 %) |
Jul 07 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Grant | A | 0.00 | 6,661 | 0 | 30,322 | 23.7 K to 30.3 K (+28.15 %) |
Jul 07 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Payment of Exercise | F | 107.79 | 404 | 43,547 | 29,521 | 29.9 K to 29.5 K (-1.35 %) |
Jul 07 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Payment of Exercise | F | 106.47 | 1,637 | 174,291 | 29,925 | 31.6 K to 29.9 K (-5.19 %) |
Jul 07 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Grant | A | 0.00 | 6,661 | 0 | 31,562 | 24.9 K to 31.6 K (+26.75 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | M | 73.21 | 88,406 | 6,472,203 | 0 | |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | M | 73.21 | 1,365 | 99,932 | 0 | |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | A | 106.47 | 74,720 | 7,955,438 | 74,720 | |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Sell | S | 110.00 | 88,406 | 9,724,660 | 266,501 | 354.9 K to 266.5 K (-24.91 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Buy | M | 73.21 | 88,406 | 6,472,203 | 354,907 | 266.5 K to 354.9 K (+33.17 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Sell | S | 110.00 | 1,365 | 150,150 | 266,501 | 267.9 K to 266.5 K (-0.51 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Buy | M | 73.21 | 1,365 | 99,932 | 267,866 | 266.5 K to 267.9 K (+0.51 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Payment of Exercise | F | 107.79 | 1,559 | 168,045 | 266,501 | 268.1 K to 266.5 K (-0.58 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Payment of Exercise | F | 106.47 | 11,602 | 1,235,265 | 268,060 | 279.7 K to 268.1 K (-4.15 %) |
Jul 07 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Grant | A | 0.00 | 39,059 | 0 | 279,662 | 240.6 K to 279.7 K (+16.23 %) |
Jul 07 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Payment of Exercise | F | 107.79 | 404 | 43,547 | 40,542 | 40.9 K to 40.5 K (-0.99 %) |
Jul 07 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Payment of Exercise | F | 106.47 | 1,776 | 189,091 | 40,946 | 42.7 K to 40.9 K (-4.16 %) |
Jul 07 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Grant | A | 0.00 | 6,661 | 0 | 42,722 | 36.1 K to 42.7 K (+18.47 %) |
Jul 07 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 35,564 | |
Jul 07 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 106.58 | 961 | 102,423 | 25,591 | 26.6 K to 25.6 K (-3.62 %) |
Jul 07 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 26,552 | 25.6 K to 26.6 K (+3.76 %) |
Jul 07 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Payment of Exercise | F | 106.47 | 1,057 | 112,539 | 25,591 | 26.6 K to 25.6 K (-3.97 %) |
Jul 07 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Grant | A | 0.00 | 6,661 | 0 | 26,648 | 20 K to 26.6 K (+33.33 %) |
Jul 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 294 | 0 | 29,313,492 | 29.3 M to 29.3 M (0.00 %) |
Jul 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 294 | 0 | 2,849,725 | 2.8 M to 2.8 M (+0.01 %) |
Jul 01 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 103.97 | 202 | 21,002 | 4,803 | 4.6 K to 4.8 K (+4.39 %) |
Jul 01 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 103.97 | 182 | 18,923 | 14,243 | 14.1 K to 14.2 K (+1.29 %) |
Jul 01 2020 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 103.97 | 229 | 23,809 | 4,255 | 4 K to 4.3 K (+5.69 %) |
Jul 01 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 103.97 | 208 | 21,626 | 9,190 | 9 K to 9.2 K (+2.32 %) |
Jun 30 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | M | 65.55 | 119,501 | 7,833,291 | 0 | |
Jun 30 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | M | 64.55 | 4,647 | 299,964 | 0 | |
Jun 30 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Sell | S | 102.91 | 119,501 | 12,297,848 | 240,603 | 360.1 K to 240.6 K (-33.19 %) |
Jun 30 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Buy | M | 64.55 | 119,501 | 7,713,790 | 360,104 | 240.6 K to 360.1 K (+49.67 %) |
Jun 30 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Sell | S | 102.91 | 4,647 | 478,223 | 240,603 | 245.3 K to 240.6 K (-1.89 %) |
Jun 30 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Buy | M | 64.55 | 4,647 | 299,964 | 245,250 | 240.6 K to 245.3 K (+1.93 %) |
Jun 25 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | M | 64.55 | 6,943 | 448,171 | 0 | |
Jun 25 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Sell | S | 110.00 | 6,943 | 763,730 | 21,734 | 28.7 K to 21.7 K (-24.21 %) |
Jun 25 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Buy | M | 64.55 | 6,943 | 448,171 | 28,677 | 21.7 K to 28.7 K (+31.95 %) |
Jun 25 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | M | 73.21 | 599 | 43,853 | 0 | |
Jun 25 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Sell | S | 110.00 | 400 | 44,000 | 36,061 | 36.5 K to 36.1 K (-1.10 %) |
Jun 25 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Buy | M | 73.21 | 599 | 43,853 | 36,461 | 35.9 K to 36.5 K (+1.67 %) |
Jun 23 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 72.27 | 1,423 | 102,840 | 11,861 | |
Jun 23 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 100.00 | 1,423 | 142,300 | 23,661 | 25.1 K to 23.7 K (-5.67 %) |
Jun 23 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 72.27 | 1,423 | 102,840 | 25,084 | 23.7 K to 25.1 K (+6.01 %) |
Jun 23 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Option Exercise | M | 72.86 | 7,866 | 573,117 | 7,866 | |
Jun 23 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Sell | S | 105.00 | 7,866 | 825,930 | 24,901 | 32.8 K to 24.9 K (-24.01 %) |
Jun 23 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Buy | M | 72.86 | 7,866 | 573,117 | 32,767 | 24.9 K to 32.8 K (+31.59 %) |
Jun 23 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | M | 73.21 | 7,181 | 525,721 | 0 | |
Jun 23 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Sell | S | 105.00 | 7,181 | 754,005 | 35,862 | 43 K to 35.9 K (-16.68 %) |
Jun 23 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Buy | M | 73.21 | 7,181 | 525,721 | 43,043 | 35.9 K to 43 K (+20.02 %) |
Jun 23 2020 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Sell | S | 105.31 | 9,000 | 947,790 | 21,762 | 30.8 K to 21.8 K (-29.26 %) |
Jun 22 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Grant | A | 0.00 | 25,000 | 0 | 152,188 | 127.2 K to 152.2 K (+19.66 %) |
Jun 22 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Grant | A | 0.00 | 25,000 | 0 | 98,354 | 73.4 K to 98.4 K (+34.08 %) |
Jun 18 2020 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Sell | S | 3.66 | 141,920 | 518,831 | 16,972,968 | 17.1 M to 17 M (-0.83 %) |
Jun 18 2020 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Sell | S | 3.66 | 72,080 | 264,007 | 17,114,888 | 17.2 M to 17.1 M (-0.42 %) |
Jun 16 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 3,823 | |
Jun 16 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 23,661 | 23.5 K to 23.7 K (+0.54 %) |
Jun 15 2020 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Sell | S | 3.57 | 384,025 | 1,372,160 | 17,186,968 | 17.6 M to 17.2 M (-2.19 %) |
Jun 15 2020 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Sell | S | 3.58 | 9,100 | 32,556 | 17,570,993 | 17.6 M to 17.6 M (-0.05 %) |
Jun 15 2020 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Sell | S | 3.77 | 183,875 | 692,786 | 17,580,093 | 17.8 M to 17.6 M (-1.04 %) |
Jun 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 2,192 | 143,269 | 15,058 | |
Jun 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 68.62 | 1,423 | 97,646 | 11,861 | |
Jun 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 94.19 | 2,192 | 206,464 | 23,534 | 25.7 K to 23.5 K (-8.52 %) |
Jun 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 2,192 | 143,269 | 25,726 | 23.5 K to 25.7 K (+9.31 %) |
Jun 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 95.00 | 1,423 | 135,185 | 23,534 | 25 K to 23.5 K (-5.70 %) |
Jun 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 68.62 | 1,423 | 97,646 | 24,957 | 23.5 K to 25 K (+6.05 %) |
Jun 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 36,525 | |
Jun 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 91.87 | 961 | 88,287 | 19,987 | 20.9 K to 20 K (-4.59 %) |
Jun 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 20,948 | 20 K to 20.9 K (+4.81 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 102.55 | 1 | 103 | 29,313,198 | 29.3 M to 29.3 M (0.00 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 102.55 | 1 | 103 | 2,849,431 | 2.8 M to 2.8 M (0.00 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,282 | 0 | 29,313,197 | 29.3 M to 29.3 M (0.00 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,282 | 0 | 2,849,430 | 2.8 M to 2.8 M (+0.05 %) |
May 28 2020 | INCY | INCYTE CORP | High Katherine A | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | High Katherine A | Director | Grant | A | 0.00 | 1,282 | 0 | 1,421 | 139 to 1.4 K (+922.30 %) |
May 28 2020 | INCY | INCYTE CORP | HARRIGAN EDMUND | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | HARRIGAN EDMUND | Director | Grant | A | 0.00 | 1,282 | 0 | 1,946 | 664 to 1.9 K (+193.07 %) |
May 28 2020 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 1,282 | 0 | 256,813 | 255.5 K to 256.8 K (+0.50 %) |
May 28 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 1,282 | 0 | 4,601 | 3.3 K to 4.6 K (+38.63 %) |
May 28 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 0.00 | 1,282 | 0 | 14,061 | 12.8 K to 14.1 K (+10.03 %) |
May 28 2020 | INCY | INCYTE CORP | Clancy Paul J | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 0.00 | 1,282 | 0 | 4,026 | 2.7 K to 4 K (+46.72 %) |
May 28 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 0.00 | 1,282 | 0 | 8,982 | 7.7 K to 9 K (+16.65 %) |
May 13 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 128 | 8,366 | 3,950 | |
May 13 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 128 | 8,366 | 23,534 | 23.4 K to 23.5 K (+0.55 %) |
May 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 37,486 | |
May 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 96.84 | 961 | 93,063 | 19,987 | 20.9 K to 20 K (-4.59 %) |
May 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 20,948 | 20 K to 20.9 K (+4.81 %) |
May 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 37,486 | |
May 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 96.84 | 961 | 93,063 | 19,987 | 20.9 K to 20 K (-4.59 %) |
May 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 20,948 | 20 K to 20.9 K (+4.81 %) |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 13.34 | 20,000 | 266,800 | 0 | |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 13.34 | 20,000 | 266,800 | 0 | |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 13.34 | 20,000 | 266,800 | 29,311,915 | 29.3 M to 29.3 M (+0.07 %) |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 13.34 | 20,000 | 266,800 | 2,848,148 | 2.8 M to 2.8 M (+0.71 %) |
Apr 21 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | M | 64.55 | 1,143 | 73,781 | 0 | |
Apr 21 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Sell | S | 100.00 | 1,143 | 114,300 | 21,324 | 22.5 K to 21.3 K (-5.09 %) |
Apr 21 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Buy | M | 64.55 | 1,143 | 73,781 | 22,467 | 21.3 K to 22.5 K (+5.36 %) |
Apr 21 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | M | 73.21 | 6,583 | 481,941 | 7,181 | |
Apr 21 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Sell | S | 100.00 | 6,583 | 658,300 | 35,342 | 41.9 K to 35.3 K (-15.70 %) |
Apr 21 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Buy | M | 73.21 | 6,583 | 481,941 | 41,925 | 35.3 K to 41.9 K (+18.63 %) |
Apr 20 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 72.27 | 9,488 | 685,698 | 13,284 | |
Apr 20 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 68.62 | 9,488 | 651,067 | 13,284 | |
Apr 20 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 100.00 | 9,488 | 948,800 | 22,899 | 32.4 K to 22.9 K (-29.30 %) |
Apr 20 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 72.27 | 9,488 | 685,698 | 32,837 | 23.3 K to 32.8 K (+40.64 %) |
Apr 20 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 95.00 | 9,488 | 901,360 | 22,899 | 32.4 K to 22.9 K (-29.30 %) |
Apr 20 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 68.62 | 9,488 | 651,067 | 32,837 | 23.3 K to 32.8 K (+40.64 %) |
Apr 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 17,827 | 1,165,173 | 17,250 | |
Apr 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 4,078 | |
Apr 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 90.00 | 17,827 | 1,604,430 | 22,899 | 40.7 K to 22.9 K (-43.77 %) |
Apr 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 17,827 | 1,165,173 | 40,726 | 22.9 K to 40.7 K (+77.85 %) |
Apr 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 85.68 | 965 | 82,681 | 22,899 | 23.9 K to 22.9 K (-4.04 %) |
Apr 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 23,864 | 23.7 K to 23.9 K (+0.54 %) |